{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:3657",
      "entity_text" : "Hydroxyurea",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:216239",
      "entity_text" : "Sorafenib",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Nine patients decided to follow the standard way and left on chemotherapy at relapse (FLAM, FLAG, GMALL, Clofarbine+ AraC, Hydroxyurea supported by Sorafenib or Imatinib as appropriate) and nine for IB-DLI.",
  "reading_complete" : "2020-08-05T22:24:49Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T22:23:16Z",
  "trigger" : "supported",
  "evidence" : [ "Hydroxyurea supported by Sorafenib" ],
  "pmc_id" : "7198473",
  "score" : 0
}